Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
RedHill Biopharma
RedHill Biopharma
(RDHL)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Aemcolo
Rifamycin
2018-11-16
2025
—
Talicia
Amoxicillin
,
Omeprazole magnesium,
Rifabutin
2019-11-01
2026-2042
Actinomycosis
,
Bacterial infections
,
Bacterial skin diseases
,
Chlamydia infections
,
Duodenal ulcer
,
Helicobacter infections
,
Human bites
,
Listeriosis
,
Lyme disease
,
Otitis media
,
Sinusitis
,
Soft tissue infections
,
Streptococcal infections
,
Urinary tract infections
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Amoxicillin
infections
,
dyspepsia
Omeprazole
infections
,
dyspepsia
Rifabutin
relapsing-remitting multiple sclerosis
,
crohn disease
,
infections
,
dyspepsia
,
lung diseases
,
bronchiectasis
Interferon beta
relapsing-remitting multiple sclerosis
Benzocaine
infections
,
dyspepsia
Opaganib
pancreatic neoplasms
,
neoplasms
,
cholangiocarcinoma
,
klatskin tumor
,
coronavirus infections
,
multiple myeloma
,
large b-cell lymphoma diffuse
,
kaposi sarcoma
,
covid-19
Serine
covid-19
Sodium chloride
multiple myeloma
,
sars-cov-2
Upamostat
sars-cov-2
,
covid-19
Retinol
lung diseases
,
bronchiectasis
Abc-294640
pancreatic neoplasms
,
neoplasms
,
cholangiocarcinoma
,
klatskin tumor
,
coronavirus infections
,
multiple myeloma
,
large b-cell lymphoma diffuse
,
kaposi sarcoma
,
covid-19
Bekinda
irritable bowel syndrome
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use